Fracture, Extremity, Pelvic, ED

The NICU suspected sepsis pathway standardizes the approach to the evaluation of late onset sepsis and improves recognition of and response to severe sepsis in the NICU.

This pathway provides guidance to aid providers in determining if a blood culture is indicated in a PICU/PCU patient with a fever (temperature > 38.5°C).

The clinical pathway for child with fever guides early identification, evaluation and management of patients with high-risk factors or severe signs/symptoms of disease.

The Outpatient Specialty Care and Primary Care Coronavirus Pathway provides guidance for the evaluation and care of patients with laboratory-confirmed 2019-nCoV or who is under investigation for 2019-nCoV while that patient was ill.

The ED Coronavirus Pathway provides guidance for the evaluation and care of patients with laboratory-confirmed 2019-nCoV or who is under investigation for 2019-nCoV while that patient was ill.

The Prevention of Acute Chemotherapy-Induced Nausea and Vomiting Clinical Pathway provides guidance for selecting anti-emetics and non-pharmacologic therapies for patients receiving chemotherapy.

Treatment of patients with active COVID-19 disease with guidance on severity of illness, recommendations for antivirals, steroids, immunomodulators, and convalescent plasma administration.

The PICU neonatal hyperammonemia pathway guides the care for infants < 30 days of age referred or presenting to CHOP for acute care for any abnormal or elevated ammonia level.

The Beckwith-Wiedemann Syndrome (BWS) Clinical Pathway provides guidance of care for neonates/infants born at the CHOP SDU or referred from outside institutions for further evaluation and treatment with overgrowth features such as macroglossia, hyperinsulinism, omphalocele and/or a constellation of findings suspicious for BWS.